# Neuramedy

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neuramedy

- Industry: Pharmaceuticals
- Headquarters: Seoul, South Korea
- Total disclosed funding: $6.6M
- Latest round: Series A (Jul 21, 2020)
- Investors on record: 5

## About

Founded in 2019 and based in Seoul, South Korea, Neuramedy develops pharmaceutical treatments for neurodegenerative diseases.

## Funding rounds

- Series A, Jul 21, 2020, $6.6M — KDB Bank, STIC Ventures, Hana Ventures
- Seed, Feb 1, 2019 — Korea Tech Incubator for Startup, Ulsan Creative Economy Innovation Center

## Investors

- Korea Tech Incubator for Startup — Seed
- Ulsan Creative Economy Innovation Center (https://capitalatlas.ai/funds/ulsan-creative-economy-innovation-center) — Seed
- KDB Bank — Series A
- STIC Ventures (https://capitalatlas.ai/funds/stic-ventures) — Series A
- Hana Ventures — Series A